Cargando…

The impact of specific cytokine directed treatment on severe COVID-19

Detalles Bibliográficos
Autores principales:	Reuken, P. A., Rüthrich, M. M., Hochhaus, A., Hammersen, J., Bauer, M., La Rosée, P., La Rosée, F., Stallmach, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422045/ https://www.ncbi.nlm.nih.gov/pubmed/34493799 http://dx.doi.org/10.1038/s41375-021-01411-1

Ejemplares similares

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial
por: Hammersen, J., et al.
Publicado: (2023)

P1542: RUXOLITINIB IN COVID-19 PATIENTS WITH DEFINED HYPERINFLAMMATION: THE RUXCOFLAM TRIAL
por: Birndt, Sebastian, et al.
Publicado: (2023)

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
por: La Rosée, F., et al.
Publicado: (2020)

Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter hyperferritinämischer Inflammation
por: La Rosée, P., et al.
Publicado: (2020)

Erratum zu: Interdisziplinäres COVID-Board bei SARS-CoV-2-getriggerter Hyperferritinämischer Inflammation
por: La Rosée, P., et al.
Publicado: (2020)

Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection
por: Reuken, Philipp A., et al.
Publicado: (2021)

Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure—a cautionary case series
por: Stallmach, Andreas, et al.
Publicado: (2020)

Die hämophagozytische Lymphohistiozytose bei kritisch kranken Patienten
por: Eichenauer, D. A., et al.
Publicado: (2021)

Die hämophagozytische Lymphohistiozytose bei kritisch kranken Patienten
por: Eichenauer, Dennis A., et al.
Publicado: (2021)

Lack of clinical efficacy of imatinib in metastatic melanoma
por: Ugurel, S, et al.
Publicado: (2005)

Rapid Treatment of Leukostasis in Leukemic Mantle Cell Lymphoma using Therapeutic Leukapheresis: A Case Report
por: Nguyen, Xuan Duc, et al.
Publicado: (2011)

Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open-label phase II clinical study
por: Coldewey, Sina M., et al.
Publicado: (2022)

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia
por: Frietsch, Jochen J., et al.
Publicado: (2014)

Hemophagocytic Syndrome-Associated Intravascular Large B-cell Lymphoma With Dialysis-Dependent End-Stage Renal Disease Treated With Autologous Stem Cell Transplantation Using a Modified TEAM Regimen
por: Kama, Kudret, et al.
Publicado: (2022)

Title: Cytokine release syndrome is not usually caused by secondary hemophagocytic lymphohistiocytosis in a cohort of 19 critically ill COVID-19 patients
por: Lorenz, Georg, et al.
Publicado: (2020)

Folgen nach SARS-CoV-2-Infektion einschließlich Post-COVID-Syndrom
por: Quickert, Stefanie, et al.
Publicado: (2023)

Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
por: Köse-Vogel, Nilay, et al.
Publicado: (2019)

Extracorporeal cytokine hemadsorption in severe COVID-19 respiratory failure
por: Damiani, Marianna, et al.
Publicado: (2021)

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
por: Kloc, Malgorzata, et al.
Publicado: (2020)

Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19
por: Eldanasory, Omar Abdelhay, et al.
Publicado: (2020)

Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey
por: Reuken, Philipp A., et al.
Publicado: (2020)

Prevention of the cytokine storm in COVID-19
por: Wright, David J M
Publicado: (2021)

Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption
por: Lebreton, Guillaume, et al.
Publicado: (2021)

Impact of emerging ACA on survival in chronic myeloid leukemia (CML)
por: Hehlmann, Rüdiger, et al.
Publicado: (2022)

Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis
por: Teich, Niels, et al.
Publicado: (2022)

Cytokine adsorption and ECMO in patients with COVID-19
por: Rybalko, Andrey, et al.
Publicado: (2021)

The Perception and Estimation of Others' Pain according to Children
por: Grégoire, Mathieu, et al.
Publicado: (2016)

Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation?
por: Stallmach, Andreas, et al.
Publicado: (2022)

Influence of transfusions, hemodialysis and extracorporeal life support on hyperferritinemia in critically ill patients
por: Knaak, Cornelia, et al.
Publicado: (2021)

Host or pathogen-related factors in COVID-19 severity?
por: Gortázar, Christian, et al.
Publicado: (2020)

Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
por: Tober, Romy, et al.
Publicado: (2022)

Nebulized activated protein C in a paediatric patient with severe acute respiratory distress syndrome secondary to H1N1 influenza
por: Pestaña, D., et al.
Publicado: (2011)

Adoption of a pregnancy‐specific intravenous insulin protocol (Pregnancy‐IVI) at a regional centre has equivalent safety and efficacy outcomes as a tertiary hospital
por: Rowe, Christopher W., et al.
Publicado: (2022)

Hämophagozytische Lymphohistiozytose bei unspezifischer Virusinfektion
por: Lachmann, Gunnar, et al.
Publicado: (2019)

Paraneoplastische Hyperleukozytose bei Lungenkarzinom
por: Heusinger, Josef, et al.
Publicado: (2022)

Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report
por: Giszas, Benjamin, et al.
Publicado: (2022)

A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19
por: Wagener, Gebhard, et al.
Publicado: (2022)

Impact of COVID-19 Outbreak on the Management of Patients With Severe IBD: A Domino Effect
por: Occhipinti, Vincenzo, et al.
Publicado: (2021)

Cytokine levels and pathological characteristics of a patient with severe coronavirus disease 2019: a case report
por: Kang, Kai, et al.
Publicado: (2022)

Cytokine adsorption and ECMO in patients with COVID-19
por: Nardelli, Pasquale, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lvafgkjnbaa4mk91d8oac8a82r